BPC-157 Reduces Nasal Inflammation in a Dose-Dependent Manner | Research

The takeaway

BPC-157 showed dose-dependent protection against capsaicin-induced nasal inflammation in rats, reducing mast cell infiltration, degranulation, and inflammatory cell accumulation.

Dose-dependent nasal protection
10 µg/kg BPC-157 was more protective than 10 ng/kg against capsaicin rhinitis, both significantly reducing inflammation

What the researchers found

BPC-157 at 10 µg/kg provided dose-dependent protection against capsaicin-induced rhinitis, reducing mast cell infiltration, degranulation, and inflammatory cell accumulation.

Why it matters

Rhinitis (nasal inflammation) affects hundreds of millions of people. A peptide that reduces mast cell activation and inflammatory infiltration could offer a novel therapeutic approach.

How the study worked

Rats pretreated with BPC-157 (10 µg/kg or 10 ng/kg IP) or saline, followed by intranasal capsaicin (0.05 mL/nostril of 1750 nmol/L). Animals euthanized at timepoint for histological assessment.

What this study cannot tell us

Animal study with chemical (capsaicin) model of rhinitis that may not fully represent allergic rhinitis. Short-term acute model only.

How to read the evidence

Moderate animal evidence with clear dose-response relationship and histological quantification of inflammatory markers.

When this study was published

Published in 1997, expanding BPC-157's known anti-inflammatory effects to nasal mucosa.

The bigger picture

This study expanded BPC-157's known anti-inflammatory properties from the gut to the nasal mucosa, suggesting broad mucosal protective effects.

Questions still open

Could BPC-157 be effective for allergic rhinitis in humans?
Would intranasal BPC-157 administration be more effective than systemic?

Common questions

What is capsaicin rhinitis?

Capsaicin (the active compound in hot peppers) triggers intense nasal inflammation when applied to the nose. This model mimics aspects of allergic and neurogenic rhinitis, causing mast cell activation and inflammatory cell infiltration.

How does BPC-157 reduce nasal inflammation?

BPC-157 reduced three key inflammatory processes: mast cell infiltration into nasal tissue, mast cell degranulation (releasing histamine and other irritants), and accumulation of other inflammatory cells. This suggests it acts on fundamental inflammatory pathways rather than one specific mediator.

Read the original research

Dose-dependent protective effect of BPC 157 on capsaicin-induced rhinitis in rats.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 254 Suppl 1, S9-11

View on PubMed ↗

Citation

Kalogjera, L; Ries, M; Baudoin, T; Ferencic, Z; Trotic, R; Pegan, B. (1997). Dose-dependent protective effect of BPC 157 on capsaicin-induced rhinitis in rats.. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 254 Suppl 1, S9-11.